Glaxosmithkline | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 350.71B 19.93B 2025-05
Amgen USD 150.93B 16.57B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Aurora Cannabis CAD 335.3M 101.41M 2024-12
Bausch Health Companies CAD 2.62B 826.77M 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Canopy Growth CAD 612.33M 169.68M 2024-12
Corcept Therapeutics USD 7.49B 2.21B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Indivior 904.38M 0 2025-05
J&J USD 373.47B 26.18B 2025-05
Merck USD 208.29B 17.59B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pacira USD 870M 176M 2024-12
Perrigo USD 3.51B 70M 2024-12
Pfizer USD 135.11B 8.61B 2025-05
Prestige Brands USD 3.86B 285M 2024-12
Sanofi EUR 120.97B 4.87B 2025-05
Supernus Pharmaceuticals USD 2.02B 294M 2024-12
Takeda JPY 6.61T 16.72B 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12



Glaxosmithkline Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.